Live Quote · NASDAQMLYSHealthcare· Biotechnology

Mineralys Therapeutics, Inc.

$27.69 2.98%(+$0.80)
TickerSpark Score
57/100
Mixed
70
Valuation
20
Profitability
60
Growth
84
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MLYS research report →

52-Week Range43% of range
Low
$12.59
Current
$27.69
High
$47.65
Company Overviewmineralystx.com

About the company

Mineralys Therapeutics, Inc. (MLYS) is a pioneering biopharmaceutical company currently advancing through clinical trials. Its primary focus lies in creating innovative treatments for high blood pressure and its related cardiovascular complications.

CEO
Jon Congleton
IPO
2023
Employees
51
HQ
Radnor, PA, US

Price Chart

+93.64% · this period
$47.33$30.10$12.87Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.84B
P/E
-13.51
P/S
0.00
P/B
3.59
EV/EBITDA
-11.36
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-27.92%
ROIC
-26.87%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-154,651,000 · 13.02%
EPS
$-2.29 · 37.43%
Op Income
$-170,604,000
FCF YoY
14.41%
Performance & Tape
52W High
$47.65
52W Low
$12.59
50D MA
$27.19
200D MA
$32.68
Beta
0.56
Avg Volume
1.56M

Get TickerSpark's AI analysis on MLYS

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 30, 26Congleton Jonsell58,000
Jun 30, 26Congleton Jonsell17,000
Jun 26, 26Warren Ericother104,124
Jun 26, 26Warren Ericother104,124
Jun 26, 26Warren Ericsell104,124
Jun 15, 26Rodman David Malcomother3,542
Jun 17, 26Rodman David Malcomother4,167
Jun 15, 26Rodman David Malcomother3,542
Jun 17, 26Rodman David Malcomother417
Jun 17, 26Rodman David Malcomother4,167
Coverage · MLYS

Our MLYS coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on MLYS yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate MLYS report →
Internal Compare

Similar companies

Peers in the same neighborhood.